Cyberonics, Inc., a neuromodulation company, engages in the design, development, manufacture, and marketing of implantable medical devices that provide vagus nerve stimulation (VNS) therapy for the treatment of epilepsy and treatment-resistant depression. The VNS therapy system consists of an implantable generator that delivers an electrical signal to an implantable lead attached to the left vagus nerve, as well as a bipolar lead, a programming wand and software, and a tunneling tool. The company sells its products through direct sales force in Austria, Belgium, Denmark, France, Germany, Luxemburg, the Netherlands, Norway, Spain, Sweden, Switzerland, and the United Kingdom, as well as through distribution agreements with independent distributors of various territories, including Canada, Mexico, Australia, and parts of Central and South America, Asia, the Middle East and Europe. Cyberonics was founded in 1987 and is headquartered in Houston, Texas.
Analysts'
Recommendation: | Hold |
| 30 Days Ago: | Hold |
|
| Analysts' Target: | $21 |
| Analysts' Targets |
| Canaccord Adams | $29 |
| Buy |
Friday, June 13, 2008
|
| Maxim Group | $13 |
| Sell |
Tuesday, April 08, 2008
|
$24.65 (07/10/08)
